Dignify Therapeutics Selected as a Praxis SCI Accelerate Company
Dignify Therapeutics Selected as a Praxis SCI Accelerate Company
RESEARCH TRIANGLE PARK, N.C, Oct. 22, 2024 /PRNewswire/ -- Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, has been selected as a participating company in the Praxis Spinal Cord Injury (SCI) Accelerate Program. SCI Accelerate is a commercialization program 'geared towards healthcare companies with a product ready to launch into market that will transform the lives of people living with SCI'. Under the SCI Accelerate program, Dignify and Praxis will focus on development of Dignify's drug programs to treat bladder and bowel disorders in people with SCI.
北卡羅來納州研究三角園，2024年10月22日 / PRNewswire / - 尊嚴治療（Dignify），這是一家主要開發膀胱和腸道功能障礙療法的公司，被選爲Praxis脊髓損傷（SCI）加速計劃中的參與公司之一。 SCI加速計劃是一個商業化計劃，旨在爲準備進入市場並將改變患有SCI的人生活的公司提供支持。在SCI Accelerate計劃下，尊嚴治療和Praxis將專注於開發尊嚴治療的藥物計劃，以治療患有SCI的人的膀胱和腸道障礙。
Dr. Karl B. Thor, Chief Scientific Officer of Dignify, indicated; "The Praxis SCI Accelerate Program is critically important for Dignify to ensure that the clinical development program for our products provides the efficacy, safety, and convenience that are considered valuable and most important by SCI individuals for control of bowel and bladder dysfunction. The selection of Dignify to join the Praxis SCI community confirms the unmet medical need for our therapeutics."
Dignify的首席科學官Karl B. Thor博士表示：「Praxis SCI Accelerate計劃對於確保我們產品的臨床開發計劃提供被SCI患者認爲是有價值且最重要的效力、安全性和便利性至關重要。 尊嚴治療被選爲加入Praxis SCI社區，證實了我們治療的未滿足醫療需求。」
Arushi Raina, Praxis Director of Commercialization, stated "The Praxis team was impressed by the Dignify team's approach and excited by the possibility of a bowel and bladder treatment that could be used in an accessible way to transform daily living."
Praxis商業化董事Arushi Raina表示：「Praxis團隊對尊嚴團隊的方法印象深刻，並對一種能夠以可獲得的方式用於改變日常生活的腸道和膀胱治療方法感到興奮。」
About Dignify Therapeutics
關於尊嚴治療
Founded by a team of serial entrepreneurs who are internationally recognized scientists and clinicians, Dignify's mission is to provide safe, effective, practical and convenient, "on-demand" pharmaceutical agents to treat bladder and bowel voiding dysfunctions. The company has been funded by RA Capital Management, Eshelman Ventures, the North Carolina Biotechnology Center, NIDDK, NINDS, NICHD, NIA, US Defense Department, and the One NC Small Business Program. Dignify is located at the First Flight Venture Center in Research Triangle Park, North Carolina. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
尊嚴治療由一群被國際認可的科學家和臨床醫生評爲的連續企業家成立，旨在提供安全、有效、實用和便利的「按需」藥物劑以治療膀胱和腸道排空功能障礙。該公司得到了RA Capital Management、Eshelman Ventures、North Carolina生物技術中心、NIDDk、NINDS、NICHD、NIA、美國國防部和One NC小型企業計劃的資助。尊嚴治療位於北卡羅來納州研究三角園的First Flight Venture Center。此內容完全由作者承擔責任，不一定代表美國國立衛生研究院的官方觀點。
About Praxis
關於Praxis
Praxis is a Canadian-based not-for-profit organization that leads global collaboration in SCI research, innovation and care. We accelerate the translation of discoveries and best practices into improved treatments for people with spinal cord injuries. Our work is driven by the priorities of people with SCI and led by our four teams — PLEX (people with lived experience), Cure, Care and Commercialization.
Praxis是總部位於加拿大的非營利組織，在脊髓損傷（SCI）研究、創新和護理方面帶領全球合作。我們加速發現和最佳實踐轉化爲改善脊髓損傷患者治療的成果。我們的工作由患有SCI的人們的優先事項驅動，並由我們的四個團隊領導—— PLEX（生活經驗的人），治療，護理和商業化。
PRESS CONTACT
新聞聯絡
Dignify Therapeutics
Anthony DiTonno, CEO
2 Davis Drive
Research Triangle Park, NC 27709
[email protected]
dignifytherapeutics.com
Dignify Therapeutics
安東尼·迪託諾，首席執行官
2 Davis Drive
Research Triangle Park, NC 27709
[email protected]
dignifytherapeutics.com
SOURCE Dignify Therapeutics
SOURCE Dignify Therapeutics
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎？
譯文內容由第三人軟體翻譯。
